JOINN Clinical Testing and Hangzhou Newland Technology Strategic Cooperation to Lead the Innovation of Neurological Disease Detection Technology
2025-02-26
On February 26, 2025, the international leading clinical testing organization "JOINN Clinical Testing" signed a strategic cooperation agreement with Hangzhou Newland Technology.®) technology, focusing on biomarker research for neurodegenerative and Neuroimmune Diseases, accelerating drug development and clinical application,Provide full chain solutions for global pharmaceutical customers.